Search Results 21-30 of 12016 for immunothérapie effets secondaires
The purpose of this study is to evaluate the role of interferon-gamma (IFN-γ) in antifungal defense and its potential use in adjunctive immunotherapy. Solid ...
Mayo Clinic researchers identify how P2RX7-driven regulatory T cells promote immunotherapy resistance in lung cancer, pointing to a potential new treatment ...
This medicine is to be given only by or under the direct supervision of your doctor. This product is available in the following dosage forms: Suspension. Back ...
A new study explores the combination of the intratumoral administration of the measles virus with systemic PD-L1 targeted immunotherapy using atezolizumab ...
Cryptic antigens are part of a protein — known as epitopes — that are usually hidden or inaccessible to the immune system and may be present in tumor cells. " ...
FDA approves atezolizumab with chemotherapy for certain patients with stage 3 colon cancer after a Mayo Clinic-led trial showed a 50% reduction in risk.
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Ruxolitinib phosphate may stop the growth of ...
Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Ramucirumab is a monoclonal antibody ...
A study demonstrated a potentially effective treatment for patients with bladder cancer who no longer respond to the common therapy,
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.